GLP-1 agonists linked to significantly lower long term risk of knee replacement
Greatest effect seen with sustained use and newer agents semaglutide and tirzepatide GLP-1 receptor agonist drugs, used for the treatment...
Read MoreLargest study of knee osteoarthritis tissue reveals the core biological pathways underlying osteoarthritis
A major international study led by researchers at the Kennedy Institute of Rheumatology at the University of Oxford has found...
Read MoreGIRFT launches best practice tool to support primary care colleagues to assess and manage patients with spinal pain
GIRFT has developed an interactive tool designed to support primary care practitioners to assess patients who present with spinal pain...
Read MoreWhat drives the market value of hip and knee replacement?
The global market for hip and knee replacement implant will approach US$34 billion by 2036. Hip and knee replacements are...
Read MoreExpressions of interest open for the IODA European Committee
IODA is establishing its first European Committee and is seeking expressions of interest from members based in Europe who would...
Read MoreOne of the world’s most common knee surgeries does not help and may even be harmful
Partial meniscectomy does not improve patient symptoms or function, reveals a 10-year follow-up of the FIDELITY, a placebo-surgery controlled trial....
Read MoreMedTech innovation programme set to ‘bridge vital gap between education and execution’ for Scotland
The launch of a pioneering new course in Glasgow which will help take MedTech innovations from concept to commercialisation ‘could...
Read MorePioneering study confirms the benefits of total hip arthroplasty
Total hip arthroplasty leads to the best outcomes in the treatment of moderate-to-severe hip osteoarthritis, according to a new study...
Read More